We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$223M
AUM Growth
+$77.2M
Cap. Flow
+$48M
Cap. Flow %
21.55%
Top 10 Hldgs %
25.3%
Holding
464
New
223
Increased
67
Reduced
60
Closed
103

Top Buys

1
MOH icon
Molina Healthcare
MOH
+$8.43M
2
ELV icon
Elevance Health
ELV
+$5.15M
3
INTC icon
Intel
INTC
+$4.26M
4
SNDK
Sandisk
SNDK
+$3.61M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.5M

Top Sells

1
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$4.82M
2
UNH icon
UnitedHealth
UNH
+$3.15M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$2.87M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.84M
5
LH icon
Labcorp
LH
+$2.58M

Sector Composition

1 Healthcare 52.36%
2 Technology 13.57%
3 Financials 11.27%
4 Communication Services 4.48%
5 Energy 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRWD icon
101
Ironwood Pharmaceuticals
IRWD
$635M
$613K 0.28%
+182,046
New +$473K
CVE icon
102
Cenovus Energy
CVE
$52.1B
$609K 0.27%
35,975
-16,368
-31% -$284K
ONC
103
BeOne Medicines Ltd
ONC
$32.4B
$607K 0.27%
+1,999
New +$654K
IVA
104
Inventiva
IVA
$1.09B
$603K 0.27%
+129,711
New +$603K
TRMD icon
105
TORM
TRMD
$2.91B
$599K 0.27%
+30,000
New +$633K
REPL icon
106
Replimune Group
REPL
$859M
$598K 0.27%
+61,488
New +$523K
BCS icon
107
Barclays
BCS
$93.8B
$585K 0.26%
+23,000
New +$509K
TRVI icon
108
Trevi Therapeutics
TRVI
$2.71B
$574K 0.26%
45,830
+26,142
+133% +$302K
LLY icon
109
Eli Lilly
LLY
$1.05T
$573K 0.26%
+533
New +$510K
ALNY icon
110
Alnylam Pharmaceuticals
ALNY
$35.7B
$570K 0.26%
1,433
-819
-36% -$362K
BWLP icon
111
BW LPG
BWLP
$3.09B
$568K 0.26%
+43,398
New +$554K
AXON
112
Axon Enterprise
AXON
$41.1B
$568K 0.26%
1,000
– –
MSFT icon
113
Microsoft
MSFT
$2.93T
$568K 0.26%
+1,174
New +$588K
LPCN icon
114
Lipocine
LPCN
$18.4M
$567K 0.25%
+70,576
New +$237K
LNKB
115
DELISTED
LINKBANCORP
LNKB
$558K 0.25%
67,578
+27,796
+70% +$209K
ISRG icon
116
Intuitive Surgical
ISRG
$122B
$553K 0.25%
+977
New +$520K
DAR icon
117
Darling Ingredients
DAR
$10B
$540K 0.24%
+15,000
New +$508K
CMBT
118
CMB.TECH NV
CMBT
$4.34B
$531K 0.24%
+55,000
New +$535K
OLMA icon
119
CALL
Olema Pharmaceuticals
OLMA
$1B
$528K 0.24%
260
+51
+24% +$908
EWTX icon
120
Edgewise Therapeutics
EWTX
$4.28B
$526K 0.24%
+21,204
New +$426K
LRCX icon
121
Lam Research
LRCX
$392B
$524K 0.24%
+3,061
New +$476K
CVBF icon
122
CVB Financial
CVBF
$4.03B
$522K 0.23%
+28,063
New +$537K
SBCF icon
123
Seacoast Banking Corp of Florida
SBCF
$3.3B
$514K 0.23%
16,373
-10,900
-40% -$340K
CGON icon
124
CG Oncology
CGON
$6.34B
$512K 0.23%
+12,343
New +$511K
LI icon
125
Li Auto
LI
$12.3B
$508K 0.23%
+30,000
New +$595K
3 4
5
6 7

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Persistent Asset Partners held 464 positions worth $223M, up 53% from $145M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Persistent Asset Partners deployed $48M of net new capital in Q4 2025, opening 223 new positions and adding to 67 existing holdings. Its largest new stake was Molina Healthcare: 51,285 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.15M trimmed.

  • Persistent Asset Partners's largest Q4 2025 buy was Molina Healthcare: 51,285 shares worth $8.9M.
  • Persistent Asset Partners added most to Elevance Health in Q4 2025, an estimated $5.15M increase.
  • Persistent Asset Partners's biggest Q4 2025 reduction was UnitedHealth, cutting an estimated $3.15M.
  • Persistent Asset Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2025, selling an estimated $4.82M.
  • Persistent Asset Partners's ten largest holdings make up 25% of its $223M portfolio in Q4 2025.
  • Persistent Asset Partners opened 223 new positions and closed 103 in Q4 2025.
  • Persistent Asset Partners's portfolio value rose 53% quarter-over-quarter to $223M.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.